Stockreport

BARDA Selects Edesa Biotech's Drug for U.S. Funded Platform Trial in General ARDS [Yahoo! Finance]

Edesa Biotech, Inc. - Common Shares  (EDSA) 
PDF This BARDA-funded project is expected to complement Edesa's ongoing drug development activities in COVID-19 ARDS. Paridiprubart was selected following a competitive r [Read more]